Enter GLP-1 (Glucagon-Like Peptide-1) therapy, a groundbreaking approach that's showing promise in helping people overcome nicotine addiction
Professional installation is recommended to ensure optimal performance
Kern JK, Geier DA, Adams JB, Garver CR, Audhya T, Geier MR
With NEX, pharma companies, metabolic health clinics, and prescribing networks can launch branded GLP-1 companion apps in months and integrate multiple biosensors with ease, while generating real-world evidence to strengthen reimbursement strategies and scale patient engagement globally
Pharmacokinetic interaction study of sulphasalazine in healthy Mohammadi, A., Sahebkar, A., Iranshahi, M., Amini, M., Khojasteh, R., Ghayour-Mobarhan, M., and Ferns, G